C07K 14/66
Thymopoietins
C07K14/66 (Thymopoietins) appears on 42 US grants and 8 published applications in this corpus.
Search patents in C07K- Granted patents
- 42
- Published applications
- 8
- Assignees
- 17
- Inventors
- 75
- Latest grant
- 29 Jan 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 4 | 0 |
| 1982 | 2 | 0 |
| 1983 | 3 | 0 |
| 1984 | 2 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 3 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 1 | 2 |
| 2016 | 0 | 0 |
| 2017 | 2 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Carrier immunoglobulins29 Jan 2019US 10,189,912 B2Amgen Inc.
- Carrier immunoglobulins7 Feb 2017US 9,562,107 B2Amgen Inc.
- Carrier immunoglobulins7 Feb 2017US 9,562,108 B2Amgen Inc.
- Endotoxins having nematocidal activity and methods of use thereof22 Sep 2015US 9,139,843 B2Pioneer Hi-Bred International, Inc.
- Carrier immunoglobulins27 May 2014US 8,734,796 B2Amgen Inc.
- Real-time g-protein coupled receptor (gpcr) linked bioluminescent sensing of biological targets and processes22 Dec 2022US 2022/0404337 A1Massachusetts Institute of Technology
- Carrier immunoglobulins6 Jul 2017US 2017/0190793 A1Amgen Inc.
- Carrier immunoglobulins12 Feb 2015US 2015/0044235 A1Amgen Inc.
- Carrier immunoglobulins12 Feb 2015US 2015/0044236 A1Amgen Inc.
- Endotoxins having nematocidal activity and methods of use thereof29 Nov 2012US 2012/0304337 A1Pioneer Hi-Bred International, Inc.
Most cited
By later US patents
- Peptides affecting the immune regulation and a process for their preparation46US 4,428,938 ARichter Gedeon Vegyeszeti Gyar Rt. · 1984
- Enzyme-resistant immunomodulatory peptides40US 4,505,853 AOrtho Pharmaceutical Corporation · 1985
- Conformationally restricted thymopentin-like compounds33US 4,547,489 AOrtho Pharmaceutical Corporation · 1985
- Peptides having thymopoietin-like activity32US 4,261,886 AOrtho Pharmaceutical Corporation · 1981
- Tetra and penta-peptides useful in regulating the immune system26US 5,298,490 AImmunobiology Research Institute, Inc. · 1994